Rolke James

Chief Executive Officer

DirectorOfficer

Latest Insider Transactions

3 transactions (past 365 days)

REVB
CEO
Tax Payment
-$15.8K
8,521 shares @ $1.86
Filed 2026-02-05Trade 2026-02-03
Revelation Biosciences, Inc.
REVB
CEO
Award
$479.5K
532,829 shares @ $0.90
Filed 2026-01-12Trade 2026-01-08
Revelation Biosciences, Inc.
REVB
CEO
Award
$500K
390,614 shares @ $1.28
Filed 2025-10-31Trade 2025-10-29
Revelation Biosciences, Inc.

Rolke James is a corporate insider with SEC Form 4 filings on record. No transactions have been reported in the past 12 months. Historical filings, if any, are searchable below.